IK Investment Partners (“IK”) is pleased to announce that the IK VIII Fund has reached an agreement to acquire Ellab A/S (“Ellab” or “the Company”), a leading manufacturer of thermal validation solutions, primarily used for validation for food and pharmaceutical industries, from a group of private investors. Financial terms of the transaction are not disclosed.
Diemen, the Netherlands - IK Investment Partners (“IK”) is pleased to announce that the IK 2007 Fund has reached an agreement to sell Vemedia Group (“Vemedia” or “the Group”), one of Europe’s leading producers and distributors of over the counter (OTC) drugs, food supplements and medical devices, to an entity ultimately owned by Charterhouse Capital Partners LLP (“Charterhouse”) and which also owns La Coopération Pharmaceutique (“Cooper”), a leading French OTC drug manufacturer and distributor. The parties have agreed not to disclose the financial terms of the transaction.
IK Investment Partners (“IK”) and Five Arrows Principal Investments (“FAPI”) have signed an exclusivity agreement with the founders and Naxicap Partners to invest in I@D Holding (“I@D”), a services platform to the first network of independent real estate consultants in France. The founders Malik Benrejdal, Jade Benrejdal and Jérôme Chabin as well as Naxicap Partners, shareholder since 2012, will reinvest alongside IK and FAPI.